NO863082D0 - Preparat for intramuskulaer injeksjon av legemidler, vitaminer eller vaksiner. - Google Patents

Preparat for intramuskulaer injeksjon av legemidler, vitaminer eller vaksiner.

Info

Publication number
NO863082D0
NO863082D0 NO1986863082A NO863082A NO863082D0 NO 863082 D0 NO863082 D0 NO 863082D0 NO 1986863082 A NO1986863082 A NO 1986863082A NO 863082 A NO863082 A NO 863082A NO 863082 D0 NO863082 D0 NO 863082D0
Authority
NO
Norway
Prior art keywords
intramuscular injection
vaccines
vitamins
pharmaceuticals
preparation
Prior art date
Application number
NO1986863082A
Other languages
English (en)
Norwegian (no)
Other versions
NO863082L (no
Inventor
Faruk Hadziselimovic
Original Assignee
Mepha Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mepha Ag filed Critical Mepha Ag
Publication of NO863082D0 publication Critical patent/NO863082D0/no
Publication of NO863082L publication Critical patent/NO863082L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO863082A 1984-12-07 1986-07-30 Preparat for intramuskulaer injeksjon av legemidler, vitaminer eller vaksiner. NO863082L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH586084 1984-12-07
PCT/CH1985/000172 WO1986003413A1 (en) 1984-12-07 1985-12-06 Preparations for the intramuscular injection of drugs, vitamins or vaccines

Publications (2)

Publication Number Publication Date
NO863082D0 true NO863082D0 (no) 1986-07-30
NO863082L NO863082L (no) 1986-07-30

Family

ID=4300514

Family Applications (1)

Application Number Title Priority Date Filing Date
NO863082A NO863082L (no) 1984-12-07 1986-07-30 Preparat for intramuskulaer injeksjon av legemidler, vitaminer eller vaksiner.

Country Status (9)

Country Link
EP (1) EP0204737B1 (da)
KR (1) KR870700024A (da)
AT (1) ATE74523T1 (da)
AU (1) AU5198686A (da)
DE (1) DE3585835D1 (da)
DK (1) DK365786D0 (da)
FI (1) FI863192A0 (da)
NO (1) NO863082L (da)
WO (1) WO1986003413A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267962B1 (en) 1990-12-21 2001-07-31 C-P Technology Limited Partnership Compositions and methods of treatment using peat derivatives
US5221254A (en) * 1991-04-02 1993-06-22 Alza Corporation Method for reducing sensation in iontophoretic drug delivery
NO20014746D0 (no) 2001-09-28 2001-09-28 Clas M Kjoelberg Smertelindrende middel
GB0218821D0 (en) * 2002-08-13 2002-09-18 Glaxosmithkline Biolog Sa Novel compositions
WO2006012700A1 (en) * 2004-08-04 2006-02-09 Team Health Pty Ltd Method of treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1023821A (fr) * 1950-04-21 1953-03-24 Solution stable de gluconate de calcium et procédé pour sa préparation
DE1007022B (de) * 1953-06-02 1957-04-25 Sandoz Ag Verfahren zur Verbesserung der Haltbarkeit und Loeslichkeit von Antihistamin-Praeparaten
DE1062389B (de) * 1958-02-11 1959-07-30 Wander Ag Dr A Verfahren zur Herstellung von sterilen, Kalziumsalze enthaltenden Vitamin-D-Loesungen
US4081527A (en) * 1976-12-07 1978-03-28 Pfizer Inc. Chlortetracycline compositions

Also Published As

Publication number Publication date
DK365786A (da) 1986-07-31
EP0204737B1 (de) 1992-04-08
WO1986003413A1 (en) 1986-06-19
KR870700024A (ko) 1987-02-28
AU5198686A (en) 1986-07-01
EP0204737A1 (de) 1986-12-17
ATE74523T1 (de) 1992-04-15
DK365786D0 (da) 1986-07-31
DE3585835D1 (de) 1992-05-14
FI863192A (fi) 1986-08-05
FI863192A0 (fi) 1986-08-05
NO863082L (no) 1986-07-30

Similar Documents

Publication Publication Date Title
ES2061799T3 (es) Nuevo preparado medicamentoso y procedimiento para su preparacion.
ES2061094T3 (es) Un procedimiento para la obtencion de una formulacion para disminuir el deseo imperioso de alcohol (craving) en el tratamiento del alcoholismo cronico.
NO174412C (no) Fremgangsmåte for fremstilling av en farmasöytisk formulering med programmert frigjöring for oral anvendelse
NO863620L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
ES2074513T3 (es) Utilizacion de un antagonista opiaceo para la preparacion de una composicion farmaceutica para administracion transdermica y dispositivo para el suministro percutaneo.
ES2074124T5 (es) Composicion en forma de una espuma que contiene acido 5-aminosalicilico para administracion intra-rectal.
ES2052717T3 (es) Uso de derivados de indolona para la preparacion de medicamentos para el tratamiento de la enfermedad de parkinson.
FI935844A (fi) En doseringsform foer foerdroejd befriande av ett laekemedel
PT90049A (pt) Forma de dosagem para administrar um medicamento para terapia humana
BR9807319A (pt) Microgrânulos com liberação controlada, para administração oral, contendo cisplatina, processo de preparação dos mesmos, preparação farmacêutica, e, utilização dos microgrânulos.
FI891774A0 (fi) Menetelmä lääkeaineen anto- ja/tai annostelumuodon valmistamiseksi
ES2059312T3 (es) Medicamento que puede administrarse por via nasal, procedimiento para su preparacion y su aplicacion.
SE8002715L (sv) Injicerbara lekemedel med inflammationshemmande verkan samt sett for framstellning derav
KR910005858A (ko) 지방산 요법
NO863082D0 (no) Preparat for intramuskulaer injeksjon av legemidler, vitaminer eller vaksiner.
ATE90872T1 (de) Immunostimulierende arzneimittel.
IT1241079B (it) Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
ES2043943T3 (es) Procedimiento para la preparacion de compuestos con actividad analgesica central.
SE8501312D0 (sv) Etoposide oral dosage form
ES2081279T3 (es) Utilizacion de 15-desoxiespergualina como medicamento.
SE7708622L (sv) 2-bensyl-perhydroazepiner, sett for framstellning derav och lekemedel, innehallande dem
IT1213464B (it) Forma farmaceutica per la somministrazione enterica di acido etodolico o di suoi sali, in miscela con eccipienti.
ES2032476T3 (es) Un procedimiento para preparar nuevos derivados de 2-anilinotiazolina.
AR002946A1 (es) Un conjunto para uso en el tratamiento o la prevencion de la osteoporosis en los mamiferos de acuerdo con una dieta ciclica.
ES2052475T1 (es) Preparacion farmaceutica para el tratamiento de trastornos inmunoorganicos comprendiendo pp14 o anticuerpos pp14.